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Volume 51, Number 11S Abstracts 73Ssystem may thus be important for plaque stabilization. At
the same time, the mitogenic activity of IGF-1 can promote
development of intimal hyperplasia and restenosis. Aim: To
evaluate the possible effect of IGF-1R inhibition on athero-
sclerosis progression.
Methods: 16 ApoE-/- mice were treated orally with
PPP 3.2 mg/day between 11 and 25 or 33 weeks of age.
Control group consisted of 16 animals given normal chow
diet. Atherosclerosis burden was evaluated by en face Sudan
IV staining of aortas. At the same time structure of the
atherosclerotic plaques was assessed on the crossections of
brachiocephalic trunk.
Results: Animals treated with PPP had decreased
plaque area in the aorta; this effect was stronger at 25 weeks
of age (5.2% of the aortic wall in control group and 2.2% in
PPP group) and less pronounced at 33 weeks of age (9.8%
and 11.3% respectively). Size of the lesions in brachioce-
phalic trunk was also reduced by PPP from 48.2% of cross
lumen area in control group to 27.0% in PPP group at 25
weeks and from 61.4% to 46.0% at 33 weeks respectively.
Furthermore, PPP treated lesions showed more a promi-
nent fibrous cap, had less amounts of cholesterol and a
higher cellularity.
Conclusions: Specific inhibition of IGF-1R suppressed
progression of atheroma in ApoE deficient animals. Fur-
thermore treatment with PPP has a stabilizing effect on the
advanced lesions in brachiocephalic trunk. Further studies
are required to investigate mechanisms of the described
effects.
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Objectives: Survivin (SVV) has been implicated in the
development of neointimal hyperplasia. We investigated
the effects of RNA-interference (RNAi) mediated SVV
knockdown on VS MC phenotype.
Methods: SVV knockdown was achieved by either
siRNA or lentiviral transduction of shRNA in primary
cultured VS MC from human saphenous vein. Prolifera-
tion, cell cycle kinetics, apoptosis and migration were
assessed.
Results: RNAi reduced SVV gene expression by qPCR
(75%, p  0.01), without loss of cell viability. RNAi treat-
ment increased p53 levels, whereas total cellular SVV levelswere variable. Subcellular fractionation revealed the major-
ity of SVV protein in VS MC is mitochondrial. SVV RNAi
treatment blocked proliferation in response to serum and
PDGF-AB (p 0.05, Fig 1). Cell cycle analysis revealed no
evidence of G1/S block, but an increased G2/M fraction
(27% SVV siRNA vs 17% control siRNA, p 0.05) consis-
tent with a mitotic defect. In a Transwell assay, SVV knock-
down reduced migration to PDGF-AB (74% vs controls, p
 0.01), and actin-phalloidin staining revealed disorga-
nized actin filaments and polygonal cell shape. Apoptosis
was not induced by SVV RNAi, and sensitivity to apoptotic
agonists (staurosporine, cytokines) was unchanged.
Conclusions: RNAi targeting SVV in VS MC leads to
cell cycle arrest at G2/M and impaired chemotaxis. Regu-
lation of mitosis and apoptosis in VSMC appears to involve
differentially regulated pools of SVV. Treatment of VS MC
with SVV RNAi might limit the response to vascular injury
without destabilizing the vessel wall.
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Objectives: Despite advances in revascularization fol-
lowing extremity injury the relationship between time to
restoration of flow and functional limb salvage is unknown.
The objectives of this study are to describe a large animal
model of hind limb ischemia/reperfusion and to define an
extremity ischemic threshold from clinically relevant mea-
sures of neuromuscular recovery
Methods: Sus scrofa swine (N 38; weight [kg] SD
87 kg  6.2) were randomized to iliac artery injury and
occlusion for 0 (Control), 1 (1HR), 3 (3HR), or 6 (6HR)
hours followed by vessel repair and 14 days of recovery.
Two groups underwent iliac artery division with no resto-
ration of flow (Ligation), or exposure without intervention
(Sham). A composite physiologic measure of recovery
(PMR) was generated to assess group differences across
14-days of survival. PMR included hind limb function
(Tarlov score) and electrophysiologic measures (com-
poundmuscle action potential (CMAP) amplitude, sensory
